| nosocomial respiratory syncytial virus: a threat in the modern neonatal intensive care unit. | | 2002 | 12032794 |
| direct cost analyses of palivizumab treatment in a cohort of at-risk children: evidence from the north carolina medicaid program. | use of palivizumab prophylactic therapy reduces the occurrence of hospitalizations for serious respiratory syncytial virus (rsv) lower respiratory tract infections in at-risk infants. the direct cost-benefit of palivizumab prophylaxis for infants who are born at 32 to 35 weeks' estimated gestational age (ega) during their first year of life has not been systematically examined. the objective of this study was to compare the direct costs of palivizumab prophylaxis and rsv treatment in infants who ... | 2004 | 15574623 |
| epidemiology of respiratory syncytial virus in various regions within north carolina during multiple seasons. | the centers for disease control and prevention (cdc) monitors the occurrence of respiratory syncytial virus (rsv) in the united states and has historically reported on activity at the regional level. prior to the 2007-2008 rsvseason, the cdc did not report seasonal rsv data for cities within north carolina or for the state. the purpose of the present study is to characterize rsv seasonal activity within north carolina and to determine the appropriate months in which at-risk children should recei ... | 2008 | 19256181 |